3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Multiple Myeloma
6
Venous Thromboembolism
1
Testicular Neoplasms
1
Smoldering Multiple Myeloma
1
Sezary Syndrome
1
Recurrence
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Interventions
Trimethoprim, Sulfamethoxazole Drug Combination
7
Ciprofloxacin
5
gamma-Globulins
3
Amoxicillin-Potassium Clavulanate Combination
3
liposomal amphotericin B
2
Trimethoprim
2
Sulfamethoxazole
2
Peripheral Blood Stem Cell Transplantation
2
Pentetic Acid
2
Moxifloxacin
2
Melphalan
2
Itraconazole
2
Immunoglobulins, Intravenous
2
Cyclophosphamide
2
Caspofungin
2
talquetamab
1
idecabtagene vicleucel
1
fludarabine phosphate
1
ethanolamine oleate
1
amphotericin B, deoxycholate drug combination
1
Whole-Body Irradiation
1
Watchful Waiting
1
Voriconazole
1
Vancomycin
1
Valacyclovir
1
Therapeutics
1
Tazobactam
1
Tacrolimus
1
Sodium Chloride
1
Sirolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Infections
×
Observation
×
Plasma cell
×
Clear all
NCT02624440
2015-12-08
SUTRICA
Aalborg University Hospital
Phase 2
Unknown
300 enrolled